MGI Tech Co., Ltd. (“MGI”), a global leader in life science innovation, has announced a strategic partnership with GenePoweRx, a pioneering company specializing in AI-driven personalized medicine based on genomic science. This collaboration aims to transform the landscape of predictive healthcare, precision medicine, and longevity research by combining next-generation sequencing technologies with cutting-edge AI analytics.
United by a shared commitment to making personalized and preventive healthcare more accessible and impactful, MGI and GenePoweRx will integrate their respective expertise in genomics, bioinformatics, and artificial intelligence. Their joint efforts will deliver rapid, clinical-grade genomic services to individuals and healthcare institutions around the world.
“This collaboration with MGI is a milestone for personalized healthcare,” said Dr. Kalyan Ram Uppaluri, Founder of GenePoweRx. “By integrating MGI’s state-of-the-art sequencing platforms with our proprietary AI-based insights engine, we are set to offer unmatched turnaround times, diagnostic accuracy, and interpretation depth. Our goal is to empower individuals with timely, personalized, and preventive health solutions,” added Dr. Hima Jyothi Challa, MD.
Roy Tan, General Manager of MGI Asia Pacific, said, “We are thrilled to partner with GenePoweRx in advancing the frontiers of personalized medicine. By combining MGI’s advanced genomic technologies with GenePoweRx’s innovative AI analytics, we aim to enhance genomic diagnostics and support clinicians and patients alike. This collaboration represents a major step toward realizing the full potential of personalized and preventive care for all.”